FDA
approval
· 2022-02-18
FDA Approved: BETAMETHASONE DIPROPIONATE USP, 0.05% — Original Application (TruPharma LLC)
Summary
FDA approved the Original Application for Betamethasone Dipropionate USP, 0.05% (topical corticosteroid) submitted by TruPharma LLC. It is a generic topical the…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
ORIG AP for BETAMETHASONE DIPROPIONATE USP, 0.05% (BETAMETHASONE DIPROPIONATE USP, 0.05%)